Cardiovascular Event Surveillance Following High-Dose Intravenous Mesenchymal Stem Cell Therapy: A Single-Center Real-World Observational Study
International Journal of Translational Medicine · 30.03.2026 · 6 (2) · 15
DOI: 10.3390/ijtm6020015 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Translational Medicine, online erschienen am 30.03.2026. Verfasst von Takaaki Matsuoka und 1 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The long-term cardiovascular safety of high-dose intravenous mesenchymal stem cell (MSC) therapy remains insufficiently characterized in real-world clinical settings.
Methods
We conducted a single-center retrospective observational study of patients who received high-dose intravenous MSC therapy. Cardiovascular events were identified through follow-up records. Observed event incidence was compared descriptively with age-adjusted population reference data. Statistical analyses were performed using two-sided Poisson methods.
Results
Among treated patients, a total of four cardiovascular events were recorded during follow-up. The observed incidence did not demonstrate an excess signal compared with reference population data. No clustering of events was observed in the early post-infusion period. Sensitivity analyses yielded consistent findings.
Conclusions
In this real-world cohort, high-dose intravenous MSC therapy was not associated with an apparent increase in cardiovascular event incidence. Given the observational design and limited event number, larger prospective studies are warranted to further characterize long-term cardiovascular safety.
Zitieren
APA
Matsuoka, T., & Kobayashi, N. (2026). Cardiovascular Event Surveillance Following High-Dose Intravenous Mesenchymal Stem Cell Therapy: A Single-Center Real-World Observational Study. International Journal of Translational Medicine, 6(2), 15. https://doi.org/10.3390/ijtm6020015
Vancouver
Matsuoka T, Kobayashi N. Cardiovascular Event Surveillance Following High-Dose Intravenous Mesenchymal Stem Cell Therapy: A Single-Center Real-World Observational Study. International Journal of Translational Medicine. 2026;6(2):15. doi:10.3390/ijtm6020015
BibTeX
@article{Matsuoka2026,
author = {Matsuoka, Takaaki and Kobayashi, Nana},
title = {Cardiovascular Event Surveillance Following High-Dose Intravenous Mesenchymal Stem Cell Therapy: A Single-Center Real-World Observational Study},
journal = {International Journal of Translational Medicine},
year = {2026},
volume = {6},
number = {2},
pages = {15},
doi = {10.3390/ijtm6020015}
}
EUVIMED